HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Tsuyoshi Saito Selected Research
Tsuyoshi Saito Research Topics
Disease
133
Neoplasms (Cancer)
11/2022 - 01/2002
32
Adenocarcinoma
11/2022 - 03/2002
30
Breast Neoplasms (Breast Cancer)
01/2022 - 02/2003
25
Endometrial Neoplasms (Endometrial Cancer)
12/2021 - 03/2002
19
Neoplasm Metastasis (Metastasis)
04/2022 - 07/2005
17
Uterine Cervical Neoplasms (Cancer of the Cervix)
09/2021 - 04/2006
17
Carcinoma (Carcinomatosis)
07/2020 - 10/2003
14
Sarcoma (Soft Tissue Sarcoma)
04/2021 - 11/2004
12
Carcinogenesis
11/2020 - 03/2002
12
Ovarian Neoplasms (Ovarian Cancer)
10/2018 - 01/2008
10
Synovial Sarcoma (Synovioma)
01/2013 - 04/2002
7
Colorectal Neoplasms (Colorectal Cancer)
04/2022 - 02/2010
7
Adenocarcinoma of Lung
03/2022 - 01/2013
7
Insulin Resistance
08/2019 - 04/2007
7
Adenomatous Polyposis Coli (Familial Adenomatous Polyposis)
09/2011 - 01/2002
7
Endometrial Hyperplasia
07/2007 - 03/2002
6
Rupture
04/2020 - 04/2006
6
Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
06/2018 - 10/2011
6
Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal)
01/2014 - 12/2006
5
Microsatellite Instability
01/2021 - 09/2003
5
Giant Cell Tumors (Giant Cell Tumor)
01/2019 - 01/2004
5
Adenoma (Adenomas)
09/2018 - 07/2009
4
Endometriosis
12/2021 - 06/2002
4
Hemorrhage
07/2021 - 01/2010
4
Mucinous Adenocarcinoma (Mucinous Carcinoma)
07/2021 - 01/2014
4
Lymphatic Metastasis
01/2021 - 01/2013
4
Stomach Neoplasms (Stomach Cancer)
01/2020 - 07/2005
4
Squamous Cell Carcinoma (Epidermoid Carcinoma)
09/2016 - 01/2004
4
Ovarian Epithelial Carcinoma
01/2015 - 08/2012
4
Hyperplasia
02/2013 - 03/2002
3
Lung Neoplasms (Lung Cancer)
03/2022 - 09/2016
3
Fatigue
01/2022 - 01/2016
3
Infections
12/2021 - 01/2012
3
Leiomyosarcoma
04/2021 - 10/2004
3
Placenta Accreta
03/2021 - 01/2010
3
Melanoma (Melanoma, Malignant)
01/2021 - 11/2002
3
Hypoxia (Hypoxemia)
08/2020 - 12/2006
3
Preterm Premature Rupture of the Membranes
04/2020 - 10/2007
3
Ovarian Hyperstimulation Syndrome
08/2019 - 02/2006
Drug/Important Bio-Agent (IBA)
46
Proteins (Proteins, Gene)
FDA Link
05/2022 - 07/2002
13
Catenins
IBA
11/2018 - 06/2011
12
Biomarkers (Surrogate Marker)
IBA
10/2021 - 02/2012
11
Trastuzumab (Herceptin)
FDA Link
08/2021 - 08/2015
11
Cadherins (E-Cadherin)
IBA
10/2018 - 02/2003
10
beta Catenin
IBA
12/2018 - 01/2002
9
Mucins
IBA
11/2022 - 10/2012
9
Biological Products
IBA
04/2022 - 08/2002
9
Paraffin
IBA
12/2021 - 09/2002
8
Phosphotransferases (Kinase)
IBA
10/2021 - 02/2007
8
Estrogen Receptors
IBA
10/2021 - 01/2008
8
Hormones (Hormone)
IBA
09/2021 - 08/2007
8
DNA (Deoxyribonucleic Acid)
IBA
04/2019 - 03/2002
8
Paclitaxel (Taxol)
FDA Link
Generic
06/2018 - 08/2003
7
Tight Junction Proteins
IBA
12/2021 - 02/2006
7
Formaldehyde (Formol)
FDA Link
12/2021 - 09/2002
7
Messenger RNA (mRNA)
IBA
04/2021 - 01/2002
7
Small Interfering RNA (siRNA)
IBA
11/2020 - 08/2010
7
Insulin (Novolin)
FDA Link
08/2019 - 08/2007
6
Progesterone Receptors (Progesterone Receptor)
IBA
10/2021 - 03/2004
6
ErbB Receptors (EGF Receptor)
IBA
09/2021 - 08/2012
6
Estrogens (Estrogen)
FDA Link
04/2020 - 03/2002
6
Adiponectin
IBA
03/2018 - 04/2007
6
Matrix Metalloproteinases (MMPs)
IBA
12/2017 - 06/2002
6
Antibodies
IBA
10/2016 - 02/2007
6
Collagen
IBA
01/2015 - 08/2003
5
Pharmaceutical Preparations
IBA
08/2022 - 01/2011
5
Therapeutic Uses
IBA
05/2022 - 08/2014
5
Lipoprotein Receptors (Lipoprotein Receptor)
IBA
12/2021 - 05/2016
5
Indicators and Reagents (Reagents)
IBA
04/2021 - 02/2002
5
eribulin
FDA Link
06/2019 - 01/2016
5
Androgens
IBA
10/2018 - 06/2010
4
Transcription Factors (Transcription Factor)
IBA
03/2022 - 10/2004
4
taxane
IBA
01/2022 - 01/2016
4
Claudins
IBA
12/2021 - 06/2011
4
Tyrosine Kinase Inhibitors
IBA
10/2021 - 05/2020
4
HLA Antigens (Human Leukocyte Antigens)
IBA
10/2020 - 12/2014
4
Denosumab
FDA Link
01/2020 - 12/2014
4
RNA-Directed DNA Polymerase (Reverse Transcriptase)
IBA
01/2014 - 05/2005
4
SYT-SSX fusion protein
IBA
01/2013 - 05/2004
3
Immune Checkpoint Inhibitors
IBA
05/2022 - 10/2016
3
130-nm albumin-bound paclitaxel
IBA
01/2022 - 02/2021
3
MicroRNAs (MicroRNA)
IBA
01/2021 - 09/2014
3
Cisplatin (Platino)
FDA Link
Generic
01/2021 - 01/2004
3
human ERBB2 protein
IBA
01/2021 - 01/2017
3
Glypicans
IBA
09/2020 - 04/2016
3
Enzymes
IBA
08/2020 - 06/2002
3
Antigens
IBA
07/2020 - 02/2012
Therapy/Procedure
46
Therapeutics
05/2022 - 01/2004
25
Drug Therapy (Chemotherapy)
10/2021 - 01/2004
14
Trachelectomy
01/2021 - 04/2006
10
Radiotherapy
05/2022 - 01/2004
6
Hysterectomy
01/2018 - 01/2004
5
Cervical Cerclage
07/2021 - 12/2013
4
Neoadjuvant Therapy
06/2022 - 01/2004
4
Precision Medicine
06/2021 - 09/2016
4
Cesarean Section (Caesarean Section)
03/2021 - 04/2006
4
Lymph Node Excision (Lymph Node Dissection)
04/2020 - 07/2016
3
Chemoradiotherapy
05/2022 - 08/2020
3
Immunotherapy
03/2021 - 02/2012
3
Curettage
01/2020 - 10/2011